FDA Approves the combination of belzutifin and lenvatinib for the treatment of advanced renal cell carcinoma with clear cell components
2026-09-25 03:18:40
According to CoinMeta, as reported by Reuters, FDA has approved the combination of belzutifene (Belzutifan) and lenvatinib (Lenvatinib) for the treatment of advanced renal cell carcinoma with clear cell components.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.